Skip to main content
SpringerLink
Log in
Book cover

Therapiekonzepte Onkologie pp 526–555Cite as

Nichtkleinzellige Bronchialkarzinome

  • Chapter

  • 67 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Becker N, Frentzel-Beyme R, Wagner G (1984) Krebsatlas der Bundesrepublik Deutschland, 2. Auflage, Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  2. Boring CC, Squires TS, Tong T (1993) Cancer Statistics 1993, CA/Cancer J Clin 43:7–26

    Article  CAS  Google Scholar 

  3. Zeller WJ, Schmähl D (1985) Ätiologie des Bronchialkarzinoms. In: Trandelenburg F (Hrsg): Tumoren der Atmungsorgane und des Mediastinums. Handbuch der Inneren Medizin IV/4A, Springer, Berlin Heidelberg New York Tokyo: 51–86

    Chapter  Google Scholar 

  4. World Health Organization (1982) The World Health Organization Histological Typing of Lung Tumors, 2nd edn. Am J Clin Pathol 77:123–136

    Google Scholar 

  5. Müller KM, Fisseler-Eckhoff A (1991) Pathologie der Lungentumoren in Drings P, Vogt-Moykopf I (Hrsg) Thoraxtumoren Diagnostik-Staging-gegenwärtiges Therapiekonzept, Springer-Verlag, Berlin Heidelberg New York S.5–24

    Chapter  Google Scholar 

  6. TNM-Klassifikation maligner Tumoren, 5. Auflage (1997) In: Wittekind Ch, Wagner G (Hrsg) Springer-Verlag

    Google Scholar 

  7. Drings P, Vogt-Moykopf I (1988) Das nichtkleinzellige Bronchialkarzinom, Deutsches Ärzteblatt 85:2146–2151

    Google Scholar 

  8. Bülzebruck H, Bopp R, Drings P, Bauer E, Krysa S, Probst G, van Kaick G, Müller K-M, Vogt-Moykopf I (1992) New Aspects in the Staging of Lung Cancer, Cancer 70:1102–1110

    Article  PubMed  Google Scholar 

  9. Vogt-Moykopf I, Krysa S, Probst G, Bülzebruck H, Schirren J, Branscheid D, Anyanwu E, Bauer E, Stoelben E (1991) Pathologie der Lungentumoren in Drings P, Vogt-Moykopf I (Hrsg) Thoraxtumoren Diagnostik-Staging-gegenwärtiges Therapiekonzept, Springer-Verlag, Berlin Heidelberg New York, S 170–186

    Chapter  Google Scholar 

  10. Vogt-Moykopf I (1993) Persönliche Mitteilung

    Google Scholar 

  11. Kimmig B, Vogel D, Flentje M, Wannenmacher M (1991) Pathologie der Lungentumoren in Drings P, Vogt-Moykopf I (Hrsg) Thoraxtumoren Diagnostik-Staging-gegenwärtiges Therapiekonzept, Springer-Verlag, Berlin Heidelberg New York, S 199–211

    Chapter  Google Scholar 

  12. Slater JD, Ellerbroek NA, Barkley Jr T, Mountain C, Oswald MJ, Roth JA, Peters LJ (1991) Radiation therapy following resection of non-small cell bronchogenic carcinoma. Int J Radiation Oncology Biol Phys, Vol 20:945–951

    Article  CAS  Google Scholar 

  13. Phlips P, Rocmans P, Vanderhoeft P, van Houtte P (1993) Postoperative radiotherapy after pneumonectomy: impact of modern treatment facilities. Int J Radiation Oncology Biol Phys, Vol 27:525–529

    Article  CAS  Google Scholar 

  14. Neal CR, Amdur RJ, Mendenhall WM, Knauf DG, Block AJ, Million RR (1991) Pancoast tumor: radiation therapy alone versus preoperative radiation therapy and surgery. Int J Radiation Oncology Biol Phys, Vol 21:651–660

    Article  CAS  Google Scholar 

  15. Komaki R, Mountain CF, Holbert JM, Garden AS, Shallenberger R, Cox JD, Maor MH, Guinee VF, Samuels B (1990) Superior sulcus tumors: treatment selection and results for 85 patients without metastasis (MO) at presentation. Int J Radiation Oncology Biol Phys, Vol 19:31–36

    Article  CAS  Google Scholar 

  16. Schraube P, Latz D (1993) Wertigkeit der Strahlentherapie bei der Behandlung des Pancoast-Tumors der Lunge. Strahlentherapie und Onkologie 5:265–269

    Google Scholar 

  17. Kuttig H (1986) Palliative Radiotherapie der nichtkleinzelligen Bronchialkarzinome. In: Drings P, Schnähl D, Vogt-Moykopf I (Hrsg) Bronchialkarzinom, Aktuelle Onkologie 26. Zuckschwerdt Verlag, München Bern Wien, S 366–379

    Google Scholar 

  18. Joss PA, Brunner KW (1985) Die Chemotherapie der nichtkleinzelligen Bronchialkarzinome. In: Seeber S, Niederle N (Hrs): Interdisziplinäre Therapie des Bronchialkarzinoms. Springer-Verlag, Berlin, S 75–94

    Chapter  Google Scholar 

  19. Bakowski MT, Crouch JC (1983) Chemotherapy for Non-Small Cell Lung Cancer. A Reappraisal and a Look to the Future. Cancer Treatm Rep 10:159–172

    Article  CAS  Google Scholar 

  20. Sorensen JB (1993) Treatment of non-small cell lunger cancer: new cytostatic agents. Lung Cancer 10:173–187

    Article  PubMed  CAS  Google Scholar 

  21. Eberhardt W, Wilke H, Achterrath W, Seeber S (1995) Chemotherapie des nichtkleinzelligen Bronchialkarzinoms. Onkologe 1:475–481

    Google Scholar 

  22. Folman RS, Rosman M (1988) The Role of Chemotherapy in Non-Small Cell Lung Cancer: The Community Perspective: Sem Oncol 15:16–21

    CAS  Google Scholar 

  23. Eberhardt W, Niederle N (1992) Ifosfamide in Non-Small Cell Lung Cancer: a Review, Sem Oncol 19:40–48

    CAS  Google Scholar 

  24. Haraf DJ, Devine S, Ihde DC, Vokes EE (1992) The Evolving Role of Systemic Therapy in Carcinoma of the Lung, Sem oncol 19:72–87

    CAS  Google Scholar 

  25. Ihde DC (1992) Chemotherapy of Lung Cancer, New Engl J Med 327:1434–1441

    Article  PubMed  CAS  Google Scholar 

  26. Sandler AB, Buzaid AC (1992) Lung Cancer: A Review of Current Therapeutic Modalities, Lung 170:249–265

    Article  PubMed  CAS  Google Scholar 

  27. Aaronson NK, Bullinger M, Ahmedzai S (1988) A Modular Approach to Quality-of-Life Assessment in Cancer Clinical Trials, Recent Results in Cancer Research 111:231–249, Springer-Verlag, Berlin Heidelberg

    Article  PubMed  CAS  Google Scholar 

  28. Lung Cancer Study Group (1988) The Benefit of Adjuvant Treatment for Resected Locally Advanced Non-Small Cell Lung Cancer. J Clin Oncol 6:9–17

    Google Scholar 

  29. Rose LJ (1991) Neoadjuvant and Adjuvant Therapy of Non-Small Cell Lung Cancer, Sem Oncol 18:536–542

    CAS  Google Scholar 

  30. Strauss GM, Langer MP, Elias AD, Skarin AT, Sugarbaker DJ (1992) Multi-modality Treatment of Stage III A Non-Small Cell Lung Carcinoma: A Critical Review of the Literature and Strategies for Future Research, J Clin Oncol 10:829–838

    PubMed  CAS  Google Scholar 

  31. Schaake-Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, van Houtte P, Kirkpatrick A, Koolen M, Maat B, Nijs A, Renaud A, Rodrigus P, Schuster-Uitterhoeve L, Sculier J-P, van Zandwijk N, Bartelink H (1992) Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small Cell Lung Cancer, New Engl J Med 326:524–530

    Article  PubMed  CAS  Google Scholar 

  32. Rapp E, Pater JL, Willan A, Cormier Y, Murray N, Evans WK, Hodson DI, Clark DA, Feld R, Arnold AM, Ayoub JI, Wilson KS, Latreille J, Wierzbicki RF, Hill DP (1988) Chemotherapy Can Prolong Survival in Patients with Advanced Non-Small Cell Lung Cancer — Report of a Canadian Multicenter Randomized Trial, J Clin Oncol 6:633–641

    PubMed  CAS  Google Scholar 

  33. Wilke H, Achterrath W, Gunzer U, Fink U, Preusser P, Schmoll H-J (1987) Etoposide and Split Dose of Cisplatin. A Phase II Study in Non-Small Cell Lung Cancer (NSCLC) Tumor Diagnostik und Therapie 8:194–198

    Google Scholar 

  34. Longeval E, Klastersky J (1982) Combination Chemotherapy with Cisplatin and Etoposide in Bronchogenic Squamous Cell Carcinoma and Adenocarcinoma, Cancer 50:2751–2756

    Article  PubMed  CAS  Google Scholar 

  35. Gralla RJ, Casper ES, Kelsen DP, Braun DW, Dukeman ME, Martini N, Young CW, Golbey RB (1981) Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating two Dosage Schedules, Ann Intern Med 95:414–420

    Article  PubMed  CAS  Google Scholar 

  36. Drings P, Abel U, Bülzebruck H, Stiefel P, Kleckow M, Manke H-G (1986) Experience with Ifosfamide Combinations (Etoposide or DDP) in Non-Small Cell Lung Cancer, Cancer Chemother Pharmacol 18 (Suppl 2):34–39

    Article  Google Scholar 

  37. Shephard FA, Evans WK, Goss PE, Latreille J, Logan D, Maropun J, Stewart D, Warner E, Paul K (1992) Ifosfamide, Cisplatin and Etoposide (ICE) in the Treatment of Advanced Non-Small Cell Lung Cancer, Sem Oncol 19:54–58

    Google Scholar 

  38. Shirinian M, Lee JS, Dhingra HH, Greenberg J, Hong WK (1992) Phase II Study of Cisplatin, Ifosfamide with mesna and Etoposide (PIE) Chemotherapy for Advanced Non-Small Cell Lung Cancer, Sem Oncol 19:49–53

    CAS  Google Scholar 

  39. Cullen MH, Joshi R, Chetiyawardana AD, Woodroffe CM (1988) Mitomycin, Ifosfamide and Cisplatin in Non-Small Cell Lung Cancer: Treatment Good Enough to Compare, Br J Cancer 58:359–361

    Article  PubMed  CAS  Google Scholar 

  40. von Rohr A, Anderson H, Mcintosh R, Thatcher N (1991) Phase II Study with Mitomycin, Ifosfamide and Carboplatin in Inoperable Non-Small Cell Lung Cancer, Eur J Cancer 27:1106–1108

    Article  Google Scholar 

  41. Wolf M, Havemann K, Stalleicken D, Gropp C, Maasberg M, Hans K, von Bültzingslöwen F, Klasen H, Becker H, Schroeder M, Hruska E, Hirschmann H, Gerdes H, Häßler R, Mende S, Pieritz HG, Braun C, Holle R (1988) Ergebnisse zweier multizentrischer Therapiestudien beim inoperablen nichtkleinzelligen Bronchialkarzinom, Onkologie 11:222–231

    Article  PubMed  CAS  Google Scholar 

  42. Kris MG, Gralla RJ, Wertheim MS, Kelsen DP, O’Conell JP, Burke MT, Fiore JJ, Cibas IR, Heelan RT (1986) Trial of the Combination of Mitomycin, Vindesine and Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer, Cancer Treat Rep 70:1091–1096

    PubMed  CAS  Google Scholar 

  43. Miller TP, Vance RB, Ahmann FR, Rodney SR (1986) Extensive Non-Small Cell Lung Cancer Treated with Mitomycin, Cisplatin and Vindesine (MiPE): A Southwest Oncology Group Study, Cancer Treat Rep 70:1101–1104

    PubMed  CAS  Google Scholar 

  44. Sculier JP, Klastersky J, Dumont JP, Vandermoten G, Rocmans P, Libert P, Ravez P, Becquart D, Mommen P, Dalesio O (1986) Combination Chemotherapy with Mitomycin and Vindesine in Advanced Non-Small Cell Lung Cancer: A Pilot Study by the Lung Cancer Working Party (Belium) Cancer Treat Rep 70:773–775

    PubMed  CAS  Google Scholar 

  45. Gatzemeier U, Hossfeld DK, Magnussen H, Radenbach D, Zschaber R (1987) Combination Chemotherapy with Mitomycin C, Ifosfamide and Vindesine in the Treatment of Non-Small Cell Lung Cancer, Contr Oncol 26:375–383

    Google Scholar 

  46. Durrant KR, Berry RJ, Ellis F, Ridehalgh FR, Black JM, Hamilton WS (1971) Comparison of treatment policies in inoperable bronchial carcinoma. Lancet 1:715–719

    Article  PubMed  CAS  Google Scholar 

  47. Laing AH, Berry RJ, Newman CR, Peto J (1975) Treatment of inoperable carcinoma of the bronchus. Lancet 2:1161–1164

    Article  PubMed  CAS  Google Scholar 

  48. Cormier YD, Bergeron J, la Forge, Lavandrier M, Foernier M, Chenard J, Desmeules M (1982) Benefits of polychemotherapy in advanced non small cell bronchogenic carcinoma. Cancer 50:845–849

    Article  PubMed  CAS  Google Scholar 

  49. Ganz PA, Figlin RA, Hasekell CM, la Soto N, Siau J (1989) Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Cancer 63:1271–1278

    Article  PubMed  CAS  Google Scholar 

  50. Woods RL, Williams CJ, Levi J, Page J, Bell D, Byrne M, Kerestes ZL (1990) A randomized trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer. Br J Cancer 61:608–611

    Article  PubMed  CAS  Google Scholar 

  51. Cellerino R, Tummarello D, Guido F, Isidori P, Raspugli M, Biscottini B (1991) A randomized trial off alterning chemotherapy versus best supportive care in advanced non-small cell lung cancer. J Clin Oncol 9:1454–1461

    Google Scholar 

  52. Kaasa S, Lund E, Thorud E, Hatlevoll R, Host H (1991) Symptomatic treatment versus combination chemotherapy for patiets with extensive non-small cell lung cancer. Cancer 67:2443–2447

    Article  PubMed  CAS  Google Scholar 

  53. Tubiana M, Arriagada R, Cosset JM (1985) Sequencing of drugs and radiation. Cancer 55:2131–2139

    Article  PubMed  CAS  Google Scholar 

  54. Looney WB, Goldie JH, Little JB, Hopkins HA, Read EJ, Wittes R (1985) Alternation of chemotherapy and radiotherapy in cancer management. 1. Summary of the division of cancer treatment workshop. Cancer Treatment Rep 69:769–775

    CAS  Google Scholar 

  55. Mattson K, Holsti LR, Holsti P, Jabsson M, Kajanti M, Liipo K, Mäntylä M, Korhonen SN, Nikkanen V, Nordman E, Platin LH, Pyrhönen S, Romppanien ML, Salmi R, Tammilehto L, Taskinen PJ (1988) Inoperable non-small cell lung cancer: Radiation with or without chemotherapy. Eur J Cancer Clin Oncol 24:477–482

    Article  PubMed  CAS  Google Scholar 

  56. Dillman RO, Herndon J, Seagren SL, Eaton WL Jr, Green MR (1996) Improved survival in stage III non-small-cell lunger cancer: Seven-years follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst 88:1210–1215

    Article  PubMed  CAS  Google Scholar 

  57. Morton RF, Jett JR, McGinnis WL, Earle JD, Thereau TM, Krook JE, Elliott TE, Maillard JA, Nelimark RA, Maksymuik AW, Drummond RG, Laurie JA, Kugler JW, Anderson RT (1991) Thoracic radiation therapy alone compared with combined chemo-/radiotherapy for locally unresectable non-small cell lung cancer. Ann Intern Med 115:681–686

    Article  PubMed  CAS  Google Scholar 

  58. Le Chevalier T, Arriagada R, Quoix E, Ruffle P, Martin M, Tarayre M, La combe-Terrier MJ, Douillard JY, Laplanche A (1991) Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83:417–423

    Article  PubMed  Google Scholar 

  59. Chapman R, Lewis J, Kvale P, Lehman D, Mettetal M, Doyle T, Janakiraman N (1990) A neoadjuvant trial in stage II and stage III a non-small cell lung cancer with cis-platinum and vinblastine chemotherapy. Proc Am Soc Clin Onco 19:246, A954

    Google Scholar 

  60. Gralla RJ (1988) Preoperative and adjuvant chemotherapy in non-small cell lung cancer. Sem Oncol 15 (Suppl 7): 8–12

    CAS  Google Scholar 

  61. Vohes EE, Britan JD, Hoffmann PC, Ferguson MK, Weichselbaum RR, Golomb HM (1989) Neoadjuvant vindesine, etoposide and cisplatinum for locally advanced non-small cell lung cancer. Finan report of a phase II study. Chest 96:110–113

    Google Scholar 

  62. Martini N, Kris MG, Gralla RJ, Bains MS, McCormack PM, Kayser LR, Burt ME, Zaman MB (1988) The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lmyph node metastases (N2 M0). Ann Thorac Surg 45:370–379

    Article  PubMed  CAS  Google Scholar 

  63. Einhorn LH (1988) Neoadjuvant therapy of stage III non-small cell lung cancer. Ann Thorac Surg 46:362–365

    Article  PubMed  CAS  Google Scholar 

  64. Rosell R, Gomez-Godina J, Camps C, Mastre J, Padille J, Canto A, Mate JL, La S, Roig J, Olazabai A, Canela M, Ariza A, Skagel Z, Morera-Prat J, Arad A (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. New Engl J Med 333:153–158

    Article  Google Scholar 

  65. Roth JA, Fossela F, Komaki R, Ryan MB, Putnam Jr JB, Jin Soo Lee, Dhingra H, de Caro L, Chasen M, McGavran M, Atkinson EN, Hong WK (1994) A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage III A non-small cell lung cancer. J Natl Cancer Inst 86:673–680

    Article  PubMed  CAS  Google Scholar 

  66. Bitran JD, Golomb HM, Hoffmann PC, Albain K, Evans R, Little AG, Purl S, Skosey C (1986) Protochemotherapy in non-small cell lung carcinom. An attempt to increase surgical resectability and survival: A preliminary report. Cancer 57:44–53

    Article  PubMed  CAS  Google Scholar 

  67. Takita H, Regal AM, Antkowiak JG, Rao UNM, Botsoglou NK, Lane WW (1986) Chemotherapy followed by lung resection in inoperable non-small cell lung carcinoma due to locally far-advanced disease. Cancer 57:630–635

    Article  PubMed  CAS  Google Scholar 

  68. Israel I, Breau JL, Morere JM (1986) Chimiotherapie preoperatoire dans 57 cas de cancers bronchiques epidermoides. Amalyse des responses, des complications et de la survie. Neoadjuvant Chemotherapy. Coll. INSERM/John Libbey, Eurotext 137:463–465

    Google Scholar 

  69. Clavier J, Zabbe CL, Raut Y, Briere J, Larzul KK, Kerbourch JF, Nguyen-Huu N (1986) Chimitherapie preoperatiore dans le cancera bronchiques epidermoides. Resultats d’une etude pilote portant sur 60 patients. Neo-adjuvant chemotherapy. Coll. INSERM-/John Libbey, Eurotext 137:473–478

    Google Scholar 

  70. Bonomi P, Trybulla M, Sander S, Taylor S, Howard-Ruben J, Busby J, Mattey S, Lee MS, Reddy S, Faber LP (1986) Comparison of neoadjuvant chemotherapy (Neo-CT) alone to simultaneous chemotherapy (SCT-RT) in locally advanced squamous cell bronchogenic carcinoma (sq CBS). Neo-adjuvant chemotherapy. Coll. INSERM/John Libbey Eurotext 137:505–517

    Google Scholar 

  71. Kris MG, Gralla RJ, Martinin M, Stampleman LV, Burke MT (1987) Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer. Surg Clin North Arm 67:1051–1059

    CAS  Google Scholar 

  72. Spain R (1988) Neoadjuvant mitomycin C, cisplatin, and infusion vinblastine in locally and regionally advanced non-small cell lung cancer: problems and progress from the perspective of long-term follow-up. Sem Oncol 15, Suppl 4:6–15

    CAS  Google Scholar 

  73. Burkes RL, Shepherd FA, Ginsberg RJ, Blackstein ME, Goldberg ME, Todd T, Pearson FG, Jones D, Greenwood C (1994) Induction chemotherapy with MVP in patients with stage IIIa (T1–3, N2, M0) unresectable non-small cell lung cancer (NSCLC): The Toronto experience. Proc ASCO 13:327

    Google Scholar 

  74. Pujol JL, Rossi JF, Le Chevalier T, Daures JP, Rouanet P, Douillard JY, Dubois JB, Arriagada R, Mary H, Godard P, Michel FB (1990) Pilot study of neoadjuvant ifosfamid, cisplatin, and etoposide in locally advanced non-small cell lung cancer. Eur J Cancer 26:798–801

    Article  PubMed  CAS  Google Scholar 

  75. Henriquez I, Munoz-Galindo L, Rebello J, Vieitez JM, Gonzales-Monzana R, Vargas EA, Santos M, Llorens R, Herreos J (1990) Neoadjuvant chemotherapy (NAC) with cisplatin (CDDP), mitomycin C (MMC) and vindesine (VDS) in locally advanced non small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 9:227, A876

    Google Scholar 

  76. Fischer JR, Manegold C, Bülzebruck H, Vogt-Moykopf I, Drings P (1994) Induction chemotherapy with and without recombinant human granulocyte colony-stimulating factor support in locally advanced stage IIIA/B non-small cell lung cancer. Seminars in Oncology, Vol 21, No 3, Suppl 4 (June): pp 20–27

    PubMed  CAS  Google Scholar 

  77. Takita H, Antkowiak J, Vaickus L, Driscoll D, Loewen G, Raghavan D (1993) Chemotherapy (PACC) and surgery in stage III NSCLC. Proc Am Soc Clin Oncol 12:349A, 1172

    Google Scholar 

  78. Rebello J, Aramendia JM, Bilbao I, Herreros J, Aristu JJ, Azinovic I, Fernandenz-Hidalgo O (1993) Neoadjuvant intra-arterial (IA chemotherapy for stage III non small cell lung cancer (NSCLC). Proc Am Soc Clin Ooncol 12:346, A1161

    Google Scholar 

  79. Trybulla M, Taylor SG, Bonomi P (1985) Preoperative similtaneous cisplatin/5-fluorouracil and radiotherapy in clinical stage III, non small cell bronchogenic carcinoma. Proc Am Soc Clin Oncol 4:182, A710

    Google Scholar 

  80. Strauss G, Sherman D, Schwartz J (1986) Combined modality therapy for regionally advanced stage III non small cell carcinoma of the lung employing neoadjuvant chemotherapy, radiotherapy and surgery. Proc Am Soc Clin Oncol 5:172, A675

    Google Scholar 

  81. Eagan RT, Ruud C, Lee R, Pairolero PC, Gail MH (1987) For the lung cancer study group: A pilot study of induction therapy with cyclophosphamide, doxorubicin, cis-platinum (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III MO non small cell lung cancer. Cancer Treatm Rep 71:895–900

    CAS  Google Scholar 

  82. Pincus M, Reddy S, Lee MS, Bonomi P, Taylor IV S, Rowland K, Faber LP, Warren W, Kittle CF, Hendrickson FR (1988) Preoperative combined modality therapy for stage III MO non small cell lung carcinoma. Int J Radiation Oncology Biol Phys 15:189–195

    Article  CAS  Google Scholar 

  83. Skarin A, Jochelson M, Sheldon T, Malcom A, Oliynyk P, Overholt R, Hunt M (1989) Neoadjuvant chemotherapy in marginally in resectable stage III MO non small cell lung cancer Long-Term follow-up in 41 patients. J Surg Oncol 40:266–274

    Article  PubMed  CAS  Google Scholar 

  84. Albain K, Rusch V, Crowley I, Griffin B, Beasley K, Livingston R (1991) Concurrent cisplatin (DDP), Vp-16, and chest irradiation (RT) followed by surgery for stages IIIa and IIIb non small cell lung cancer (NSCLC) A Southwest Oncology Groups (SWOG study (#8805). Proc Am Soc Clin Oncol 10:244, A836

    Google Scholar 

  85. Weitberg AB, Yahar J, Glicksman AS, Posner A, Cummings F, Browne M, Clark J, Calabresi P, Beitz J, Murray C (1993) Combined modality therapy for stage III A non small cell carcinoma of the lung. Eur J Cancer 29A: 511–515

    Article  PubMed  CAS  Google Scholar 

  86. Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Cur-ran RW, Byhardt W, Turrisi AT, Rashid Dar A, Cox JD (1995) Radiation Therapy Oncology Group (RTOG) 88–08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 87:198–205

    Article  PubMed  CAS  Google Scholar 

  87. Hazuka MB, Bunn PA (1992) Controversies in the nonsurgical treatment of stage III non-small-cell lung cancer. Am Rev Respir Dis 145:967–977

    Article  PubMed  CAS  Google Scholar 

  88. Johnson DH, Turrisi A, Pass HI (1996) Combined-modality treatment for locally advanced non-small-cell lung, Chapter 59. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AJ (eds) Lung Cancer: Principles and Practice. Lippincott-Raven Publ, Philadelphia, pp 863–873

    Google Scholar 

  89. Pass HI, Pogrebniak HW, Steinberg SM, Mulshine J, Minna JD (1992) Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 53:992–997

    Article  PubMed  CAS  Google Scholar 

  90. Manegold C, Bergman B, Chemaissani A, Dornoff W, Drings P, Kellokompu-Lethinen P, Liippo K, Mattson K, v Pawel J, Ricci S, Serdholm C, Stahel RA, Wagenius G, v Walree N, ten Bokkel-Huinink W (1997) Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer. Ann Oncol 8:525–529

    Article  PubMed  CAS  Google Scholar 

  91. Le Chevalier T, Brisgand D, Douillard JY, Pujol JL, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, Gottfried M, Ruffie P, Panizo A, Gaspard MH, Ravaioli A, Besenval M, Besson F, Martinez A, Berthaud P, Tursz T (1994) Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 12:360–367

    PubMed  Google Scholar 

  92. Bonomi PD, Kim K, Chang A (1996) Phase III trial comparing etoposide (E) cisplatin versus T taxol (T) with cisplatin-G-CSF (G) versus cisplatin in advanced non-small-cell lung cancer: Eastern Cooperative Oncology Group (ECOG) Proc Am Soc Clin Oncol 15:1145 (abstr); 382

    Google Scholar 

  93. Langer CJ, Leighton JC, Comis RL (1995) Paclitacel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: A phase II toxicity, response, and survival analysis. J Clin Oncol 13:1860–1870

    PubMed  CAS  Google Scholar 

  94. Mattson K, Vansteenkiste J, Saarinen A, Bargetzi G, Fillet E, Teixeira E, Gatzenmeier U, Berille J, Bougon N, Jekunen A (1997) Phase II study of docetaxel alternating with cisplatin for advanced NSCLC preliminary report of European multi-center trial. Proc Amer Soc Clin Oncol 16:1707 (abstr.) 474a

    Google Scholar 

  95. Abratt RP, Bezwoda WR, Goedhals L, Hacking DJ (1997) Weekly gemcitabine with monthly cisplatin: Effective chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol 15:744–749

    Google Scholar 

  96. Wolf M, Hans K, Becker H, Hässler R, v Bültzingslöwen F, Goerg R, Klaasen HA, Dannhäuser J, Holle R, Pfab R, Havemann K (1994) Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small-cell lung cancer. Sem Oncol 21 (Suppl. 4):42–47

    CAS  Google Scholar 

  97. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S (1996) Hyperfractionated radiation therapy with or without concurrent low-dose carboplatin/etoposide for stage III non-small-cell lung cancer: A randomized study. J Clin Oncol 14:1065–1070

    PubMed  CAS  Google Scholar 

  98. Stewart LA, Pignon JP (1995) Chemotherapy in non-small-cell lung cancer: A metaanalysis using updated data on individual patients from 52 randomised clinical trials. Brit Med J 311:899–909

    Article  Google Scholar 

  99. Eberhardt W, Wilke H, Stamatis G et al. (1998) Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: Mature results of a phase II trial. J Clin Oncol 2:622–634

    Google Scholar 

  100. Facere B, Pawel JV, Krauß C (1998) Phase II study of docetaxel and cisplatin in a circadian timing as first line chemotherapy in advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 17:482a

    Google Scholar 

Download references

Authors
  1. P. Drings
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Wannenmacher
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Innere Klinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen, Deutschland

    Siegfried Seeber  & Jochen Schütte  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Drings, P., Wannenmacher, M. (1998). Nichtkleinzellige Bronchialkarzinome. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10493-4_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10493-4_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-63821-6

  • Online ISBN: 978-3-662-10493-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation